Nanoform Finland (OSTO:NANOFS) Accounts Payable & Accrued Expense : kr22.17 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Accounts Payable & Accrued Expense?

Nanoform Finland's quarterly accounts payable & accrued expense declined from Sep. 2023 (kr12.99 Mil) to Dec. 2023 (kr9.88 Mil) but then increased from Dec. 2023 (kr9.88 Mil) to Mar. 2024 (kr22.17 Mil).

Nanoform Finland's annual accounts payable & accrued expense declined from Dec. 2021 (kr19.02 Mil) to Dec. 2022 (kr13.10 Mil) and declined from Dec. 2022 (kr13.10 Mil) to Dec. 2023 (kr9.88 Mil).

Nanoform Finland Accounts Payable & Accrued Expense Historical Data

The historical data trend for Nanoform Finland's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland Accounts Payable & Accrued Expense Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.03

12.51

19.02

13.10

9.88

Nanoform Finland Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															26.28	22.01	12.99	9.88	22.17

Nanoform Finland Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Nanoform Finland (OSTO:NANOFS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OSTO:NANOFS) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

NANOFH:Finland 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (OSTO:NANOFS) Headlines

No Headlines